Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Allen

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B studyM J Ratain, G Rosner, S L Allen, et al.
American Journal of Hematology|January 12, 1999
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimenR L Bayer, S M Lichtman, S L Allen, et al.
Blood|June 1, 1991
Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisisA Foti, H G Ahuja, S L Allen, et al.
The American Journal of Medicine|March 1, 1987
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumorsM H Kaplan, M Susin, S G Pahwa, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Leukemia|November 1, 1991
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot studyW Kreis, D R Budman, K Chan, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
The Journal of Experimental Medicine|April 1, 1995
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cellsS Hashimoto, M Dono, M Wakai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B studyM J Ratain, G Rosner, S L Allen, et al.
American Journal of Hematology|January 12, 1999
Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimenR L Bayer, S M Lichtman, S L Allen, et al.
Blood|June 1, 1991
Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisisA Foti, H G Ahuja, S L Allen, et al.
The American Journal of Medicine|March 1, 1987
Neoplastic complications of HTLV-III infection. Lymphomas and solid tumorsM H Kaplan, M Susin, S G Pahwa, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
Leukemia & Lymphoma|July 27, 2016
Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion ScheduleS M Lichtman, A Mittelman, D R Budman, et al.
Leukemia|November 1, 1991
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot studyW Kreis, D R Budman, K Chan, et al.
Investigational New Drugs|January 1, 1996
Phase II study of elsamitrucin (BMY-28090) for the treatment of patients with refractory/relapsed non-Hodgkin's lymphomaS L Allen, L P Schacter, S M Lichtman, et al.
The Journal of Experimental Medicine|April 1, 1995
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cellsS Hashimoto, M Dono, M Wakai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
Pageof 13